ReP USP - Resultado da busca

Artigo de periodico
Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis (2021)
Viani, Gustavo Arruda; Gouveia, Andre G.; Louie, Alexander V.; Korzeniowski, Martin; Pavoni, Juliana Fernandes ; Hamamura, Ana Carolina; Moraes, Fabio Y
Source: Radiotherapy and Oncology. Unidades: FFCLRP, FMRP
Subjects: NEOPLASIAS ÓSSEAS, NEOPLASIAS MAMÁRIAS, ESTUDOS PROSPECTIVOS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANI, Gustavo Arruda et al. Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis. Radiotherapy and Oncology, v. 164, p. 245-250, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.radonc.2021.09.031. Acesso em: 29 maio 2024.
APA
Viani, G. A., Gouveia, A. G., Louie, A. V., Korzeniowski, M., Pavoni, J. F., Hamamura, A. C., & Moraes, F. Y. (2021). Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis. Radiotherapy and Oncology, 164, 245-250. doi:10.1016/j.radonc.2021.09.031
NLM
Viani GA, Gouveia AG, Louie AV, Korzeniowski M, Pavoni JF, Hamamura AC, Moraes FY. Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis [Internet]. Radiotherapy and Oncology. 2021 ; 164 245-250.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.radonc.2021.09.031
Vancouver
Viani GA, Gouveia AG, Louie AV, Korzeniowski M, Pavoni JF, Hamamura AC, Moraes FY. Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis [Internet]. Radiotherapy and Oncology. 2021 ; 164 245-250.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.radonc.2021.09.031
Artigo de periodico
Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide (2020)
Faustino, Alexandre Ciuffi Corrêa; Arruda, Gustavo Viani; Hamamura, Ana Carolina
Source: Clinics. Unidade: FMRP
Subjects: QUIMIOTERAPIA, RADIOTERAPIA, SOBREVIDA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAUSTINO, Alexandre Ciuffi Corrêa e ARRUDA, Gustavo Viani e HAMAMURA, Ana Carolina. Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide. Clinics, v. 75, p. 1-6, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1553. Acesso em: 29 maio 2024.
APA
Faustino, A. C. C., Arruda, G. V., & Hamamura, A. C. (2020). Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide. Clinics, 75, 1-6. doi:10.6061/clinics/2020/e1553
NLM
Faustino ACC, Arruda GV, Hamamura AC. Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide [Internet]. Clinics. 2020 ; 75 1-6.[citado 2024 maio 29 ] Available from: https://doi.org/10.6061/clinics/2020/e1553
Vancouver
Faustino ACC, Arruda GV, Hamamura AC. Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide [Internet]. Clinics. 2020 ; 75 1-6.[citado 2024 maio 29 ] Available from: https://doi.org/10.6061/clinics/2020/e1553
Artigo de periodico
Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence: a meta-analysis (2020)
Viani, Gustavo Arruda; Arruda, Caio V.; Hamamura, Ana Carolina; Faustino, Alexandre Ciuffi Corrêa; Danelichen, Anielle Freitas Bendo; Guimarães, Flávio da Silva
Source: American Journal of Clinical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANI, Gustavo Arruda et al. Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence: a meta-analysis. American Journal of Clinical Oncology, v. 43, n. 2, p. 73-81, 2020Tradução . . Disponível em: https://doi.org/10.1097/COC.0000000000000635. Acesso em: 29 maio 2024.
APA
Viani, G. A., Arruda, C. V., Hamamura, A. C., Faustino, A. C. C., Danelichen, A. F. B., & Guimarães, F. da S. (2020). Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence: a meta-analysis. American Journal of Clinical Oncology, 43( 2), 73-81. doi:10.1097/COC.0000000000000635
NLM
Viani GA, Arruda CV, Hamamura AC, Faustino ACC, Danelichen AFB, Guimarães F da S. Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence: a meta-analysis [Internet]. American Journal of Clinical Oncology. 2020 ; 43( 2): 73-81.[citado 2024 maio 29 ] Available from: https://doi.org/10.1097/COC.0000000000000635
Vancouver
Viani GA, Arruda CV, Hamamura AC, Faustino ACC, Danelichen AFB, Guimarães F da S. Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence: a meta-analysis [Internet]. American Journal of Clinical Oncology. 2020 ; 43( 2): 73-81.[citado 2024 maio 29 ] Available from: https://doi.org/10.1097/COC.0000000000000635
Artigo de periodico
Palliative radiotherapy for gastric cancer: is there a dose relationship between bleeding response and radiotherapy? (2020)
Arruda, Gustavo Viani; Arruda, Caio Viani; Hamamura, Ana Carolina; Faustino, Alexandre Ciuffi Corrêa; Danelichen, Anielle Freitas Bendo; Matsuura, Fernando Kojo; Neves, Leonardo Vicente Fay
Source: Clinics. Unidade: FMRP
Subjects: NEOPLASIAS GÁSTRICAS, RADIOTERAPIA, CUIDADOS PALIATIVOS, NEOPLASIAS INTESTINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Gustavo Viani et al. Palliative radiotherapy for gastric cancer: is there a dose relationship between bleeding response and radiotherapy?. Clinics, v. 75, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1644. Acesso em: 29 maio 2024.
APA
Arruda, G. V., Arruda, C. V., Hamamura, A. C., Faustino, A. C. C., Danelichen, A. F. B., Matsuura, F. K., & Neves, L. V. F. (2020). Palliative radiotherapy for gastric cancer: is there a dose relationship between bleeding response and radiotherapy? Clinics, 75, 1-7. doi:10.6061/clinics/2020/e1644
NLM
Arruda GV, Arruda CV, Hamamura AC, Faustino ACC, Danelichen AFB, Matsuura FK, Neves LVF. Palliative radiotherapy for gastric cancer: is there a dose relationship between bleeding response and radiotherapy? [Internet]. Clinics. 2020 ; 75 1-7.[citado 2024 maio 29 ] Available from: https://doi.org/10.6061/clinics/2020/e1644
Vancouver
Arruda GV, Arruda CV, Hamamura AC, Faustino ACC, Danelichen AFB, Matsuura FK, Neves LVF. Palliative radiotherapy for gastric cancer: is there a dose relationship between bleeding response and radiotherapy? [Internet]. Clinics. 2020 ; 75 1-7.[citado 2024 maio 29 ] Available from: https://doi.org/10.6061/clinics/2020/e1644
Artigo de periodico
Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics? (2019)
Viani, Gustavo Arruda; Hamamura, Ana Carolina; Faustino, Alexandre Ciuffi Corrêa; Arruda, Felipe Teles de
Source: International Brazilian Journal of Urology. Unidade: FMRP
Subjects: RADIOTERAPIA, NEOPLASIAS PROSTÁTICAS, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANI, Gustavo Arruda et al. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?. International Brazilian Journal of Urology, v. 45, n. 2, p. 237-245, 2019Tradução . . Disponível em: https://doi.org/10.1590/s1677-5538.ibju.2018.0039. Acesso em: 29 maio 2024.
APA
Viani, G. A., Hamamura, A. C., Faustino, A. C. C., & Arruda, F. T. de. (2019). Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics? International Brazilian Journal of Urology, 45( 2), 237-245. doi:10.1590/s1677-5538.ibju.2018.0039
NLM
Viani GA, Hamamura AC, Faustino ACC, Arruda FT de. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics? [Internet]. International Brazilian Journal of Urology. 2019 ; 45( 2): 237-245.[citado 2024 maio 29 ] Available from: https://doi.org/10.1590/s1677-5538.ibju.2018.0039
Vancouver
Viani GA, Hamamura AC, Faustino ACC, Arruda FT de. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics? [Internet]. International Brazilian Journal of Urology. 2019 ; 45( 2): 237-245.[citado 2024 maio 29 ] Available from: https://doi.org/10.1590/s1677-5538.ibju.2018.0039
Artigo de periodico
Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: is there any clinical difference? (2019)
Viani, Gustavo Arruda; Hamamura, Ana Carolina; Faustino, Alexandre Ciuffi Corrêa
Source: International Brazilian Journal of Urology. Unidade: FMRP
Subjects: RADIOTERAPIA, NEOPLASIAS PROSTÁTICAS, AGENTE TÓXICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANI, Gustavo Arruda e HAMAMURA, Ana Carolina e FAUSTINO, Alexandre Ciuffi Corrêa. Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: is there any clinical difference?. International Brazilian Journal of Urology, v. 45, n. 6, p. 1105-1112, 2019Tradução . . Disponível em: https://doi.org/10.1590/s1677-5538.ibju.2018.0842. Acesso em: 29 maio 2024.
APA
Viani, G. A., Hamamura, A. C., & Faustino, A. C. C. (2019). Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: is there any clinical difference? International Brazilian Journal of Urology, 45( 6), 1105-1112. doi:10.1590/s1677-5538.ibju.2018.0842
NLM
Viani GA, Hamamura AC, Faustino ACC. Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: is there any clinical difference? [Internet]. International Brazilian Journal of Urology. 2019 ; 45( 6): 1105-1112.[citado 2024 maio 29 ] Available from: https://doi.org/10.1590/s1677-5538.ibju.2018.0842
Vancouver
Viani GA, Hamamura AC, Faustino ACC. Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: is there any clinical difference? [Internet]. International Brazilian Journal of Urology. 2019 ; 45( 6): 1105-1112.[citado 2024 maio 29 ] Available from: https://doi.org/10.1590/s1677-5538.ibju.2018.0842

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation